126 related articles for article (PubMed ID: 15929104)
21. Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.
Hay AE; Meyer RM
Hematol Oncol Clin North Am; 2014 Feb; 28(1):49-63. PubMed ID: 24287067
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD55 and CD59 on peripheral blood cells in patients with lymphoproliferative disease of granular lymphocytes.
Isoda A; Tsukamoto N; Mitsui T; Yamane A; Hatsumi N; Matsushima T; Murakami H; Nojima Y; Karasawa M
Int J Lab Hematol; 2007 Feb; 29(1):52-7. PubMed ID: 17224008
[TBL] [Abstract][Full Text] [Related]
23. Radiation in early-stage Hodgkin lymphoma.
Meyer RM
Clin Adv Hematol Oncol; 2013 Mar; 11(3):162-89. PubMed ID: 23598983
[No Abstract] [Full Text] [Related]
24. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
[TBL] [Abstract][Full Text] [Related]
25. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
26. Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy.
Hodgson DC; Pintilie M; Gitterman L; Dewitt B; Buckley CA; Ahmed S; Smith K; Schwartz A; Tsang RW; Crump M; Wells W; Sun A; Gospodarowicz MK
Hematol Oncol; 2007 Mar; 25(1):11-5. PubMed ID: 17036376
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy of BOVAPEC in the primary treatment of Hodgkin's lymphoma intermediate stages].
Raida L; Papajík T; Indrák K; Herman M; Paucek B; Zapletalová J
Vnitr Lek; 2007 Jan; 53(1):31-7. PubMed ID: 17472013
[TBL] [Abstract][Full Text] [Related]
28. In male Hodgkin lymphoma patients, impaired fertility may be improved by non-gonadotoxic therapy.
Laddaga FE; Masciopinto P; Nardelli C; Vacca MP; Masciandaro P; Arcuti E; Cicinelli E; Specchia G; Musto P; Gaudio F
Br J Haematol; 2022 Jan; 196(1):110-115. PubMed ID: 34462914
[TBL] [Abstract][Full Text] [Related]
29. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
30. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Martin WG; Ristow KM; Habermann TM; Colgan JP; Witzig TE; Ansell SM
J Clin Oncol; 2005 Oct; 23(30):7614-20. PubMed ID: 16186594
[TBL] [Abstract][Full Text] [Related]
31. Combined modality treatment of Hodgkin's lymphoma.
Klimm B; Engert A
Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
[TBL] [Abstract][Full Text] [Related]
32. Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors.
Carella AM; Corradini P; Mussetti A; Ricardi U; Vitolo U; Viviani S
Ann Hematol; 2018 Aug; 97(8):1301-1315. PubMed ID: 29802458
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
Canellos GP
J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972
[No Abstract] [Full Text] [Related]
34. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Hodgkin lymphoma: the past, present, and future.
Evens AM; Hutchings M; Diehl V
Nat Clin Pract Oncol; 2008 Sep; 5(9):543-56. PubMed ID: 18679394
[TBL] [Abstract][Full Text] [Related]
36. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Federico M; Luminari S; Iannitto E; Polimeno G; Marcheselli L; Montanini A; La Sala A; Merli F; Stelitano C; Pozzi S; Scalone R; Di Renzo N; Musto P; Baldini L; Cervetti G; Angrilli F; Mazza P; Brugiatelli M; Gobbi PG;
J Clin Oncol; 2009 Feb; 27(5):805-11. PubMed ID: 19124807
[TBL] [Abstract][Full Text] [Related]
37. Hodgkin's disease associated cholestasis in a man with thymoma.
Opeskin K; Burke M; McCaffrey G; Nandurkar H
Pathology; 2003 Aug; 35(4):349-51. PubMed ID: 12959773
[No Abstract] [Full Text] [Related]
38. Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents.
Jones GL; Taylor PR; Windebank KP; Hoye NA; Lucraft H; Wood K; Angus B; Proctor SJ
Br J Cancer; 2007 Jul; 97(1):29-36. PubMed ID: 17533403
[TBL] [Abstract][Full Text] [Related]
39. Misleading Ga-67 uptake in a patient with Hodgkin's disease, mediastinal deviation, and pulmonary compression.
Stark P; Steinmetz A; Hefetz M; Hardoff R
Clin Nucl Med; 2002 Dec; 27(12):898-9. PubMed ID: 12607876
[No Abstract] [Full Text] [Related]
40. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
